Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of theabrownin to preparation of medicine for treating liver cancer

A technology for the treatment of liver cancer and theabrownin, applied in drug combinations, antineoplastic drugs, pharmaceutical formulations, etc., can solve the problems of unclear mechanism of action and its impact, and achieve the effect of inhibiting tumor growth and promoting apoptosis

Active Publication Date: 2020-11-03
杭州茗褐生物科技有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, the relationship between theabrownin and JNK signaling pathway and its role in inhibiting liver cancer are still unknown, and its mechanism of action and its impact are still unclear, and follow-up studies are needed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of theabrownin to preparation of medicine for treating liver cancer
  • Application of theabrownin to preparation of medicine for treating liver cancer
  • Application of theabrownin to preparation of medicine for treating liver cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Example 1: Effect of theabrownin on the proliferation of Huh7 cells

[0025] HepG2, SK-hep1, and Huh7 cells were treated with theabrownin, and the cell viability after 24 and 48 hours was observed. cells in 8 x 10 3 Cells / well were seeded on a 96-well plate and cultured in 200 µl medium for 24 hours. Add 200µl of theabrownin at different concentrations, culture in the incubator for 24 hours and 48 hours respectively, suck off the supernatant, add 20µl of MTT solution (5.0mg / ml) to each well and incubate at 37°C for 4 Hour. Carefully suck out the culture medium in the wells, then add 150 µl DMSO to each well, shake on a shaker at low speed for 10 minutes to fully dissolve the crystals, and measure the optical density (OD) value at 490 nm with a microplate reader. Inhibition rate (IR, %)=[1−(theabrownin treated OD / untreated OD)]*100%. 100 mg / ml, 200 mg / ml and 300 mg / ml were used as the low, medium and high doses of theabrownin for the next experiment.

[0026] The re...

Embodiment 2

[0027] Example 2: Effect of theabrownin on apoptosis of Huh7 cells

[0028] DAPI staining and flow cytometry were used to observe the apoptosis morphology of Huh7 cells after theabrownin treatment. cells in 8 x 10 3 The density of each well was inoculated on a 24-well plate, and treated with low, medium, and high doses of theabrownin for 24 hours, and the control group was added with a culture medium without theabrownin, and cultured for 24 hours. Cells were fixed with 4% paraformaldehyde for 30 minutes at room temperature, and washed with PBS buffer solution for 3 times, 5 minutes each time. Permeabilize with PBS containing 0.5% Triton-X-100 at room temperature for 30 minutes, choose PBS buffer solution to wash 3 times, 5 minutes each time. Add DAPI staining solution for 4 minutes at room temperature, choose PBS buffer solution to wash 3 times, 5 minutes each time. Unstained and stained cells were observed using a fluorescence microscope. Five funnels in each group were u...

Embodiment 3

[0031] Example 3: Effect of theabrownin on apoptosis of SK-hep1 cells

[0032]DAPI staining and flow cytometry were used to observe the apoptotic morphology of SK-hep1 cells after theabrownin treatment.

[0033] The result is as image 3 As shown in A, with the increase of theabrownin concentration, more and more apoptotic cells appeared chromatin condensation, nuclear pyknosis and apoptotic bodies (arrows). like image 3 As shown in B, as the concentration of theabrownin increased, the early and late apoptosis rates of SK-hep1 cells increased significantly, indicating that theabrownin induced apoptosis of SK-hep1 cells in a dose-dependent manner.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of theabrownin to preparation of a medicine for treating liver cancer, and belongs to the technical field of the purpose of the theabrownin. The application specifically comprises an application of the theabrownin to preparation of the medicine for treating liver cancer, and theabrownin promotes apoptosis of hepatocellular carcinoma Huh7 cells by activating aJNK signal channel and inhibits growth of liver cancer transplanted tumors. Various tests prove that the theabrownin has remarkable anti-proliferation and apoptosis-promoting effects on the Huh7 cells, and has a dose-dependent effect. The theabrownin promotes apoptosis of the Huh7 cells by activating the JNK signal channel and inhibits growth of zebra fish liver cancer transplantation tumors. Theinhibition rate of the theabrownin on tumors can reach 48.1%. In addition, the theabrownin promotes apoptosis of P53 wild Sk-hep1 cells by activating a P53 channel and regulating mRNA expression of downstream apoptosis related genes PUMA, NOXA, Bax, Bcl-2 and the like.

Description

technical field [0001] The invention belongs to the technical field of theabrownin application, and in particular relates to the application of theabrownin in the preparation of drugs for treating liver cancer. Background technique [0002] Theabrownin (TB) is a complex natural polymer extracted from tea leaves that is soluble in water but insoluble in ethyl acetate and n-butanol. It is composed of polyphenols such as theaflavin and thearubigin Derived from further oxidation, it is naturally present in black tea, green tea and black tea. Theabrownin is of great benefit to improving the comprehensive metabolic balance of the human body. It has the effects of lowering blood sugar, blood lipids, blood pressure, and uric acid. It is also a promising anticancer candidate substance. [0003] Liver cancer is a malignant tumor of the liver, which can be divided into two categories: primary and secondary. Primary malignant tumors of the liver originate from the epithelial or mesenc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/82A61P35/00A61K127/00
CPCA61K36/82A61P35/00
Inventor 张进
Owner 杭州茗褐生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com